The researchers found that PAC-MANN correctly identified people with pancreatic cancer 98% of the time. When used together with the CA 19-9 test, it could find early-stage cancer with 85% accuracy.

Pancreatic and colorectal cancers are two of the most concerning cancers. Both are notoriously difficult to detect in their early stages, primarily due to the lack of specific early symptoms and their ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways. In ...